VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot U6638AA: VAERS reports

22 VAERS reports list lot U6638AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2020-04-08 and 2022-07-16. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
22
Reports
5%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1335%
General / Systemic (non-local)1027%
Neurological38%
Allergic / Anaphylactic38%
Gastrointestinal38%
Musculoskeletal25%
Thrombotic / Hematological13%
Respiratory13%
Dermatological (non-injection-site)13%

Where reports came from

U.S. state of the reporter, where given (top 11).

Colorado5
Oregon3
Louisiana3
Missouri2
Florida2
Texas1
Illinois1
Mississippi1
Michigan1
Washington1
New York1

Reports by month received

2020-042
2020-062
2020-076
2020-085
2020-093
2021-012
2021-061
2022-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.